Dupilumab reduces atopic dermatitis lesion severity and extent in children <12 years of age with moderate-to-severe AD: interim results from the PEDISTAD real-world registry

被引：0

作者：

Lee, Lara Wine ^{[1
]}

Irvine, Alan D. ^{[2
]}

Ramien, Michele ^{[3
,4
]}

Marcoux, Danielle ^{[5
,6
]}

Baselga, Eulalia ^{[7
]}

de Graaf, Marlies ^{[8
]}

Antila, Martti ^{[9
]}

Rosario Filho, Nelson A. ^{[10
]}

Lara-Corrales, Irene ^{[11
]}

Joyce, Joel C. ^{[12
]}

Gupta, Rajan ^{[13
]}

Redman, Patrick ^{[14
]}

Zhang, Annie ^{[13
]}

机构：

[1] Med Univ South Carolina, Charleston, SC USA

[2] Trinity Coll Dublin, Dublin, Ireland

[3] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada

[4] Univ Calgary, Calgary, AB, Canada

[5] Univ Montreal, Montreal, PQ, Canada

[6] CHU St Justine, Univ Hosp Ctr, Montreal, PQ, Canada

[7] Hosp St Joan Deu, Barcelona, Spain

[8] Univ Med Ctr Utrecht, Utrecht, Netherlands

[9] Clin Alergia, Sorocaba, SP, Brazil

[10] Univ Fed Parana, Curitiba, Brazil

[11] Hosp Sick Children, Toronto, ON, Canada

[12] Endeavor Hlth, Skokie, IL USA

[13] Sanofi, Cambridge, MA USA

[14] Regeneron Pharmaceut Inc, Tarrytown, NY USA

来源：

关键词：

atopic dermatitis; pediatric; eczema area and severity index; dupilumab;

D O I：

10.1093/bjd/ljae266.066

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

692

引用

页数：2

Dupilumab reduces atopic dermatitis lesion severity and extent in children &lt;12 years of age with moderate-to-severe AD: interim results from the PEDISTAD real-world registry